FindTrial
Sign In

Placebo B

DRUG7 trials

Sponsors

University of Utah, John D. Dingell VA Medical Center, University of Waterloo, Santa Barbara Cottage Hospital, Sciwind Biosciences APAC CO Pty. Ltd.

Conditions

Adenomatous Polyposis ColiAlcohol Withdrawal SyndromeDepressionDiabetes Mellitus, Type 1DigestiveGastrointestinal HealthHealthyNonalcoholic Steatohepatitis

Phase 1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants
CompletedNCT04389775
Sciwind Biosciences APAC CO Pty. Ltd.Nonalcoholic Steatohepatitis, Obesity, Type 2 Diabetes Mellitus
Start: 2020-03-29End: 2021-09-29Updated: 2021-10-28
Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin
RecruitingNCT07634770
Sam Chun Dang Pharm. Co. Ltd.Diabetes Mellitus, Type 1
Start: 2026-05-29End: 2026-10-01Target: 16Updated: 2026-06-09

Phase 2

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
CompletedNCT01187901
University of UtahAdenomatous Polyposis Coli
Start: 2010-04-30End: 2014-07-31Updated: 2016-06-17

Phase 4

Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
WithdrawnNCT03788889
Santa Barbara Cottage HospitalAlcohol Withdrawal Syndrome
Start: 2019-04-12End: 2019-04-12Updated: 2019-09-19

Unknown Phase

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.
WithdrawnNCT02223299
John D. Dingell VA Medical CenterDepression
Start: 2015-11-30End: 2015-11-30Updated: 2020-02-21
Glutamate Supplementation in Young Men
CompletedNCT03425578
University of WaterlooHealthy
Start: 2018-03-19End: 2018-10-02Updated: 2019-06-12
Efficacy of Two Enzyme Cocktails in Healthy Adults
TerminatedNCT06710392
The Archer-Daniels-Midland CompanyDigestive, Gastrointestinal Health
Start: 2025-05-29End: 2026-02-28Updated: 2026-05-12

Related Papers

Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog.
2023-06-2427 citations
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis
Gut2022-05-3020 citations
Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis
JAMA Oncology2018-02-0877 citations
Abstract LB-074: Regression of duodenal neoplasia in familial adenomatous polyposis patients using COX and EGFR inhibition: A randomized placebo-controlled trial
Cancer Research2016-07-15